Lung cancer stands as a prominent malignancy globally, ranking high in both incidence and mortality rates. It ranks as the second most frequent cancer diagnosis, regardless of gender. Although smoking is the main culprit behind lung cancer, radon and asbestos exposure can also play a role in its pathogenesis. Common symptoms include coughing, shortness of breath, and notably, hemoptysis, with manifestations stemming from local tumors, intrathoracic spread, distant metastases, or paraneoplastic syndromes. The majority of lung cancer diagnoses occur symptomatically, typically at advanced stages, indicative of poor prognosis. Imaging modalities, such as, Computed Tomography (CT), Ultrasonography (US), Magnetic Resonance Imaging (MRI), chest Radiographs, Positron Emission Tomography combined with CT (PET-CT), and bone scintigraphy, play crucial roles in diagnosis and disease staging. Despite the prevalence of advanced-stage presentations, early detection of lung cancer remains paramount, as it offers patients the potential for curative treatment through the implementation of appropriate radiological techniques. Radiologists act as crucial members of the multidisciplinary team dedicated to lung cancer, contributing expertise throughout the patient journey – from initial screening and definitive diagnosis to treatment planning and evaluation of treatment response.